Nogalamycin [nogalamycin]
topical
- Terms
-
U-15167
Persistent link
https://www.medvik.cz/link/D009621
Definition
An anthrocycline from a Streptomyces nogalater variant. It is a cytolytic antineoplastic that inhibits DNA-dependent RNA synthesis by binding to DNA.
- DUI
- D009621 MeSH Browser
- CUI
- M0014939
- CAS
- 2,6-Epoxy-2H-naphthaceno(1,2-b)oxocin-14-carboxylic acid, 11-((6-deoxy-3-C-methyl-2,3,4-tri-O-methyl-alpha-L-mannopyranosyl)oxy)-4-(dimethylamino)-3,4,5,6,9,11,12,13,14,16-decahydro-3,5,8,10,13-pentahydroxy-6,13-dimethyl-9,16-dioxo-, methyl ester, (2R-(2alpha,3beta,4alpha,5beta,6alpha,11beta,13alpha,14alpha))-
- Previous indexing
- Glycosides (1966-1975); Antibiotics (1966); Antibiotics, Antineoplastic (1967-1975); Naphthacenes (1966-1975)
- History note
- 91(76); was see under DAUNORUBICIN 1981-90; was see under NAPHTHACENES 1976-80
- Public note
- 91; was see under DAUNORUBICIN 1981-90; was see under NAPHTHACENES 1976-80
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AG
- agonists 0
- AA
- analogs & derivatives 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BI
- biosynthesis 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- EC
- economics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 0
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UR
- urine 0
...
Occurrences in Medvik records
D
Chemicals and Drugs
D02.455.426.559.847.562.050.200.150
Carubicin
D02.455.426.559.847.562.050.200.650
Nogalamycin
D02.455.426.559.847.562.050.200.650.500
Menogaril
D04.615.562.050.200.150
Carubicin
D04.615.562.050.200.650
Nogalamycin
D04.615.562.050.200.650.500
Menogaril
D09.408.051.059.200.150
Carubicin
D09.408.051.059.200.650
Nogalamycin
D09.408.051.059.200.650.500
Menogaril